Kelly A Romano - Net Worth and Insider Trading

Kelly A Romano Net Worth

The estimated net worth of Kelly A Romano is at least $37,516 dollars as of 2024-09-20. Kelly A Romano is the Director of Athira Pharma Inc and owns about 80,715 shares of Athira Pharma Inc (ATHA) stock worth over $37,516. Details can be seen in Kelly A Romano's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kelly A Romano has not made any transactions after 2024-06-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Kelly A Romano

To

Kelly A Romano Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kelly A Romano owns 3 companies in total, including Dorman Products Inc (DORM) , UGI Corp (UGI) , and Athira Pharma Inc (ATHA) .

Click here to see the complete history of Kelly A Romano’s form 4 insider trades.

Insider Ownership Summary of Kelly A Romano

Ticker Comapny Transaction Date Type of Owner
DORM Dorman Products Inc 2017-11-09 director
UGI UGI Corp 2023-01-27 director
ATHA Athira Pharma Inc 2024-06-24 director

Kelly A Romano Latest Holdings Summary

Kelly A Romano currently owns a total of 1 stock. Kelly A Romano owns 80,715 shares of Athira Pharma Inc (ATHA) as of June 24, 2024, with a value of $37,516.

Latest Holdings of Kelly A Romano

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ATHA Athira Pharma Inc 2024-06-24 80,715 0.46 37,516

Holding Weightings of Kelly A Romano


Kelly A Romano Form 4 Trading Tracker

According to the SEC Form 4 filings, Kelly A Romano has made a total of 3 transactions in Athira Pharma Inc (ATHA) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Athira Pharma Inc is the acquisition of 42,400 shares on June 24, 2024, which cost Kelly A Romano around $100,064.

Insider Trading History of Kelly A Romano

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kelly A Romano Trading Performance

GuruFocus tracks the stock performance after each of Kelly A Romano's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kelly A Romano is -41.58%. GuruFocus also compares Kelly A Romano's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kelly A Romano within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kelly A Romano's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kelly A Romano

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 4.04 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 9 LIMIT LIMIT LIMIT LIMIT LIMIT

Kelly A Romano Ownership Network

Ownership Network List of Kelly A Romano

No Data

Ownership Network Relation of Kelly A Romano

Insider Network Chart

Kelly A Romano Owned Company Details

What does Dorman Products Inc do?

Who are the key executives at Dorman Products Inc?

Kelly A Romano is the director of Dorman Products Inc. Other key executives at Dorman Products Inc include SVP & Sales Jeffery Darby , director & 10 percent owner & President & COO Steven L Berman , and SVP & CIO Donna M. Long .

Dorman Products Inc (DORM) Insider Trades Summary

Over the past 18 months, Kelly A Romano made no insider transaction in Dorman Products Inc (DORM). Other recent insider transactions involving Dorman Products Inc (DORM) include a net sale of 6,600 shares made by Jeffery Darby , a net sale of 58,929 shares made by Steven L Berman , and a net purchase of 1,000 shares made by G. Michael Stakias .

In summary, during the past 3 months, insiders sold 65,529 shares of Dorman Products Inc (DORM) in total and bought 0 shares, with a net sale of 65,529 shares. During the past 18 months, 66,029 shares of Dorman Products Inc (DORM) were sold and 1,293 shares were bought by its insiders, resulting in a net sale of 64,736 shares.

Dorman Products Inc (DORM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Dorman Products Inc Insider Transactions

No Available Data

Kelly A Romano Mailing Address

Above is the net worth, insider trading, and ownership report for Kelly A Romano. You might contact Kelly A Romano via mailing address: C/o Dorman Products, Inc., 3400 East Walnut Street, Colmar Pa 18915.

Discussions on Kelly A Romano

No discussions yet.